On this week’s Trending News EU episode, Jack and Ollie discuss a few recent EU-based newsworthy items including UK funding for genomic sequencing (0:32), world-first gene base editing treatment to treat leukemia (4:07), EU medical device regulation extensions (7:57), and the current NHS crisis including Prime Minister Rishi Sunak’s speech, strikes, and labour shortages (10:52).
Podcast Tags: healthcare, healthcare news, NHS, strike, public health, genomic sequencing, genetics, genetic testing, gene therapy, leukemia, cancer, EU, regulation, medical device, Rishi Sunak,
Source Links:
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at
1-888-VYNAMIC.
Jen Burke, Director
Jack Young, Director
Oliver May, Manager
Vynamic, an Inizio Advisory company, is a leading management consulting partner to global health organizations across Life Sciences, Health Services, and Health Technology. Founded and headquartered in Philadelphia, Vynamic has offices in Boston, Durham NC, New York, and London. Our purpose is simple: We believe there is a better way. We are passionate about shaping the future of health, and for more than 20 years we’ve helped clients transform by connecting strategy to action.
Through a structured, yet flexible delivery model, our accomplished leaders work as an extension of client teams, enabling growth, performance, and culture. Vynamic has been recognized by organizations like Great Place to Work and Business Culture Awards for being leaders and innovators in consulting, company culture, and health. Visit Vynamic.com to discover how we can help transform your
organization or your career.
Industry leaders discuss breaking barriers in health equity, inclusive research, and patient access at Inizio’s NYC panel.
Read moreFrance is making waves in AI-driven healthcare—scaling fast, innovating boldly, and balancing Silicon Valley agility...
Listen nowVynamic enabled omnichannel marketing, AI-driven sales, and governance, boosting HCP engagement, consumer reach, and sales impact.
Read more